Revvity, ES-230-C, ValiScreen Human Nociceptin Opioid Receptor NOP (ORL1) Cell Line, CHO-K1 Cells

Name: ValiScreen Human Nociceptin Opioid Receptor NOP (ORL1) Cell Line, CHO-K1 Cells
Brand: Revvity
SKU: ES-230-C

The ValiScreen™ Nociceptin Opioid Receptor NOP (ORL1) Cell Line is a stable cell line expressing the human recombinant Nociceptin Opioid Receptor NOP (ORL1) receptor, in CHO-K1 host cells. This specialized cell line is specifically designed and manufactured for use in drug discovery and development, particularly for high-throughput screening assays. The ValiScreen™ Nociceptin Opioid Receptor NOP (ORL1) Cell Line is a stable cell line expressing the human recombinant Nociceptin Opioid Receptor NO

Catalog Number: ES-230-C

Pricing

Send an RFQ.

View RFQ List

Category

Insect Cell Expression Systems

Pack Size2 vial

TagsCell Analysis Research & Development Cell Lines & Stem Cells GPCR Cell Lines

Description

Revvity's ValiScreen cell lines are provided in two vials of frozen cells, each containing ~2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line. Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway. Revvity’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Please use link above to accept Terms and Conditions or to request an agreement for commercial use.

Specifications

General

G-Alpha Natural Receptor	Gi/Go
Validation	BindingcAMPGTPγS
Application	cAMP Drug Discovery & Development
Brand	ValiScreen
Host Cell Line	CHO-K1
Host Species	Human
One Unit Contains	2 vial(s)
Product Group	Cell Line
Receptor	Opioid
Second Messenger Release	GTP exchange
Shipping Conditions	Shipped in Dry Ice
Special Ordering Information	Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
Target Class	GPCR
Therapeutic Area	Central Nervous System Inflammation Pain
Unit Size	5 million cells
Validation	Binding cAMP GTPγS

Ordering

Notice

Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:

[email protected]

Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.

Revvity, ES-230-C, ValiScreen Human Nociceptin Opioid Receptor NOP (ORL1) Cell Line, CHO-K1 Cells

Send an RFQ.

General

Notice

More from Revvity.

Ultima Gold ³H Quenched Standards, 20 mL Vial

Fontus 8i Mini Liquid Handling Workstation, 8-Tip Varispan

Fontus Workstation, Dual-Arm, 8-Tip Varispan, 96 Main Array, Standard

Fontus NGS Workstation, Dual-Arm, 8-Tip Varispan, 96 Main Array, Expanded

More from Revvity.

Ultima Gold ³H Quenched Standards, 20 mL Vial

Fontus 8i Mini Liquid Handling Workstation, 8-Tip Varispan

Fontus Workstation, Dual-Arm, 8-Tip Varispan, 96 Main Array, Standard

Fontus NGS Workstation, Dual-Arm, 8-Tip Varispan, 96 Main Array, Expanded